IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Corona Remidies IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Iifl Securities , Jm Financial , Kotak Mahindra Capital Company are the merchant bankers of Corona Remidies IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 30th April 2025.
Corona Remidies IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
1,342.04 cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Iifl Securities
IPO by BRLM so far:
89
City:
Ahmedabad
IPO so far:
14
Revenue (annualised):
₹
1203.60
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 25.12x
Corona Remidies IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Iifl Securities Limited is the book-running lead manager of the Corona Remidies IPO. [●] is the Registrar for Corona Remidies IPO.
Corona Remidies IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Corona Remidies IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on Pharmaceutical formulation company. The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Corona Remidies IPO size is ₹ [●] with fresh issue size of ₹ [●] and Offer for sale being ₹ Nil
The IPO allotment date for Corona Remidies IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Corona Remidies IPO allotment status on the registrars website, [●]. Corona Remidies IPO refund dates are [●].
Corona Remidies IPO is expected to be listed on [●].
The upper price band for the Corona Remidies IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Corona Remidies IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Corona Remidies IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Corona Remidies IPO is finalised.
The merchant banker for Corona Remidies IPO is Iifl Securities Limited , Jm Financial Limited , Kotak Mahindra Capital Company Limited . Iifl Securities Limited , Jm Financial Limited , Kotak Mahindra Capital Company Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Corona Remidies IPO RHP for further details.
The registrar for Corona Remidies IPO is [●]. Investors can go to [●] registrar website for IPO allotment status, refund processing, and other queries related to Corona Remidies IPO through their official website or helpline.
Corona Remidies IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 1,342.04 Cr.
Sector: Pharmaceutical
IPO so far:
22
Merchant Banker:
Iifl Securities
IPO by BRLM so far:
89
City:
Ahmedabad
IPO so far:
14
Revenue (annualised):
₹ 1,203.60 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 25.12x
Corona Remidies IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Corona Remidies Financial Review Page
Merchant Banker(s) of Corona Remidies IPO: Iifl Securities Limited , Jm Financial Limited , Kotak Mahindra Capital Company Limited
Corona Remidies IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Corona Remidies IPO listed at a listing price of against the offer price of .
The current market price of Corona Remidies is .
Why Us?
